Kratos Defense and 5 Other Stocks That Can Benefit From the U.S. Restocking Its Missiles

Dow Jones
03/06

President Donald Trump has signaled that he’s happy to fight a drawn-out war in Iran. The longer the conflict lasts, the more money the U.S. will have to spend replenishing its stock of missiles.

That’s good news for defense contractors, although there are major concerns about them running out of crucial technologies.

“With the recent attacks on Iran and escalation in the Middle East, we expect further increases in missile production will be required to restock the arsenal to maintain readiness,” Truist Securities analyst Michael Ciarmoli wrote in a research note.

Lockheed Martin, Northrop Grumman, L3Harris Technologies, Karman, Kratos Defense & Security Solutions, and Ducommon are the stocks that are most “exposed” to a surge in missile spending, Ciarmoli added.

The Trump administration plans to meet with defense executives on Friday and the Pentagon could seek an extra $50 billion in funding to support operations in the Middle East, Reuters reported on Wednesday, citing people familiar with the matter.

The White House didn’t immediately respond to a request for comment from Barron’s.

The big challenge for defense contractors is making missiles fast enough, given there are choke points in supply chains for components including castings, seekers, solid rocket motors, and other complex electronic components.

Production line speeds also vary, Ciarmoli said. Active or “hot” production lines that are already running typically take between eight and 12 weeks to make missiles, while cold lines building the technology from scratch can take 12 to 28 months.

The prospect of a drawn-out war in the Middle East has given defense stocks a significant lift this year. The iShares U.S. Aerospace & Defense exchange-traded fund is up 12% in 2026, compared with a 0.2% drop for the S&P 500.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10